Tissue-nonspecific Alkaline Phosphatase [EPC]

4759 reported adverse events

Drugs of this class: ASFOTASE ALFA

These side effects are most commonly reported by patients taking drugs of the Tissue-nonspecific Alkaline Phosphatase [EPC] class:

# Side effect Count
0 INJECTION SITE PAIN 518
1 INJECTION SITE ERYTHEMA 413
2 INJECTION SITE REACTION 393
3 FATIGUE 335
4 PAIN 329
5 BLOOD ALKALINE PHOSPHATASE INCREASED 266
6 PAIN IN EXTREMITY 230
7 ARTHRALGIA 226
8 INJECTION SITE BRUISING 206
9 INJECTION SITE SWELLING 186
See all common reactions for Tissue-nonspecific Alkaline Phosphatase [EPC]

Drugs of the Tissue-nonspecific Alkaline Phosphatase [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOFRACTURE 3 0.5000
1 VITAMIN B6 ABNORMAL 10 0.4762
2 VITAMIN B6 DECREASED 36 0.3871
3 VITAMIN B6 INCREASED 19 0.2111
4 INJECTION SITE DEFORMATION 10 0.2000
5 HYPOPHOSPHATASIA 6 0.1429
6 BLOOD ALKALINE PHOSPHATASE ABNORMAL 48 0.0865
7 BLOOD ALKALINE PHOSPHATASE DECREASED 41 0.0668
8 RICKETS 10 0.0625
9 INJECTION SITE HYPERTROPHY 9 0.0489
See all enriched reactions for Tissue-nonspecific Alkaline Phosphatase [EPC]